Your browser doesn't support javascript.
loading
The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation.
Taube, Janis M; Akturk, Guray; Angelo, Michael; Engle, Elizabeth L; Gnjatic, Sacha; Greenbaum, Shirley; Greenwald, Noah F; Hedvat, Cyrus V; Hollmann, Travis J; Juco, Jonathan; Parra, Edwin R; Rebelatto, Marlon C; Rimm, David L; Rodriguez-Canales, Jaime; Schalper, Kurt A; Stack, Edward C; Ferreira, Cláudia S; Korski, Konstanty; Lako, Ana; Rodig, Scott J; Schenck, Emanuel; Steele, Keith E; Surace, Michael J; Tetzlaff, Michael T; von Loga, Katharina; Wistuba, Ignacio I; Bifulco, Carlo B.
Afiliação
  • Taube JM; Department of Dermatology, Johns Hopkins School of Medicine, Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA jtaube1@jhmi.edu.
  • Akturk G; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York City, USA.
  • Angelo M; Department of Pathology, Stanford University School of Medicine, Palo Alto, California, USA.
  • Engle EL; Department of Dermatology, Johns Hopkins School of Medicine, Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA.
  • Gnjatic S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York City, USA.
  • Greenbaum S; Department of Pathology, Stanford University School of Medicine, Palo Alto, California, USA.
  • Greenwald NF; Department of Pathology, Stanford University School of Medicine, Palo Alto, California, USA.
  • Hedvat CV; Cancer Biology Program, Stanford University School of Medicine, Palo Alto, California, USA.
  • Hollmann TJ; Bristol-Myers Squibb, New York, New York City, USA.
  • Juco J; Dermatopathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
  • Parra ER; Merck & Co Inc, Kenilworth, New Jersey, USA.
  • Rebelatto MC; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Rimm DL; AstraZeneca, Gaithersburg, Maryland, USA.
  • Rodriguez-Canales J; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Schalper KA; AstraZeneca, Gaithersburg, Maryland, USA.
  • Stack EC; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Ferreira CS; Jounce Therapeutics Inc, Cambridge, Massachusetts, USA.
  • Korski K; Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Penzberg, Germany.
  • Lako A; Pharma Research and Early Development (pRED), Roche Innovation Center Munich, Penzberg, Germany.
  • Rodig SJ; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.
  • Schenck E; Harvard Medical School, Boston, Massachusetts, USA.
  • Steele KE; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.
  • Surace MJ; Harvard Medical School, Boston, Massachusetts, USA.
  • Tetzlaff MT; AstraZeneca, Gaithersburg, Maryland, USA.
  • von Loga K; AstraZeneca, Gaithersburg, Maryland, USA.
  • Wistuba II; AstraZeneca, Gaithersburg, Maryland, USA.
  • Bifulco CB; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
J Immunother Cancer ; 8(1)2020 05.
Article em En | MEDLINE | ID: mdl-32414858
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Coloração e Rotulagem / Imuno-Histoquímica / Imunofluorescência / Microambiente Tumoral / Imunoterapia Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Coloração e Rotulagem / Imuno-Histoquímica / Imunofluorescência / Microambiente Tumoral / Imunoterapia Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article